Literature DB >> 32441698

State of eHealth in Cancer Care: Review of the Benefits and Limitations of eHealth Tools.

Susan Doyle-Lindrud1.   

Abstract

BACKGROUND: eHealth has the potential to improve patient access to care through the use of various tools.
OBJECTIVES: This article provides a review of some eHealth technologies, including a discussion of their benefits and limitations. An overview of studies using eHealth technologies are summarized, and future directions are explored.
METHODS: A review of the eHealth literature was conducted, with a focus on outcomes of telehealth interventions in cancer care.
FINDINGS: eHealth can transform health care by expanding the reach of clinical cancer care. Examples of this expansion of care include patients who live in remote areas with limited access to oncology providers, patients who find travel challenging, and patients who prefer the convenience of communicating with their provider from their home. Such telehealth interventions can increase patient satisfaction, but additional research is needed to further evaluate patient outcomes.

Entities:  

Keywords:  eHealth; supportive care; technology; teleconsult; telehealth; telemedicine

Mesh:

Year:  2020        PMID: 32441698     DOI: 10.1188/20.CJON.S1.10-15

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  2 in total

Review 1.  Ethical Principles in Digital Palliative Care for Children: The MyPal Project and Experiences Made in Designing a Trustworthy Approach.

Authors:  Tina Garani-Papadatos; Pantelis Natsiavas; Marcel Meyerheim; Stefan Hoffmann; Christina Karamanidou; Sheila A Payne
Journal:  Front Digit Health       Date:  2022-03-18

2.  Oncology patients' communication experiences during COVID-19: comparing telehealth consultations to in-person visits.

Authors:  Richard L Street; Katherine Treiman; Elissa C Kranzler; Rebecca Moultrie; Laura Arena; Nicole Mack; Reese Garcia
Journal:  Support Care Cancer       Date:  2022-02-09       Impact factor: 3.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.